Intracellular pH homeostasis and metabolic processes

Intracellular pH (pHi) homeostasis and metabolic processes refer to the complex regulatory networks that maintain the acid-base balance within cells, a condition vital for enzymatic function and metabolic flux (Casey et al., 2010, Nature Reviews Molecular Cell Biology). This homeostasis is primarily managed by a suite of membrane transporters and enzymes, including sodium-hydrogen exchangers (NHEs), bicarbonate transporters, and carbonic anhydrases (CAs), which respond to metabolic acid production (Parks et al., 2013, Nature Reviews Cancer). Maintaining a stable pHi is essential for optimal enzyme kinetics, protein stability, and the regulation of metabolic pathways such as glycolysis and oxidative phosphorylation. In many diseases, particularly cancer, these processes are altered; tumor cells typically maintain an alkaline pHi to support rapid proliferation while acidifying the extracellular environment to facilitate invasion and immune evasion (White et al., 2017, Trends in Cell Biology). While the term describes a broad physiological state rather than a single protein, the individual components of these pathways are significant therapeutic targets. Drugs such as carbonic anhydrase inhibitors or monocarboxylate transporter (MCT) inhibitors are designed to disrupt these pH-regulating mechanisms to induce selective toxicity in diseased cells. Consequently, modulating these processes represents a strategic approach in oncology and the treatment of ischemic injuries. Therapeutic challenges include the potential for systemic acidosis and the need for high selectivity to avoid disrupting pH balance in healthy tissues.

Other names

Cellular pH regulationAcid-base homeostasisMetabolic pH control

Inhibition of ion exchangers, bicarbonate transporters, or carbonic anhydrases to disrupt pH gradients and metabolic byproduct export.